Buch, Englisch, 296 Seiten, Format (B × H): 152 mm x 229 mm, Gewicht: 620 g
From the Laboratory Bench to the Patient's Bedside
Buch, Englisch, 296 Seiten, Format (B × H): 152 mm x 229 mm, Gewicht: 620 g
ISBN: 978-0-12-391875-8
Verlag: William Andrew Publishing
Zielgruppe
<p>The pharmaceutical industry, investment banks with an interest in healthcare, healthcare investors, management consultancies with healthcare practices, economists with an interest in healthcare, reimbursement agencies, regulatory bodies (e.g. the FDA and EMEA), government, politicians and policy makers.</p>
Fachgebiete
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Public Health, Gesundheitsmanagement, Gesundheitsökonomie, Gesundheitspolitik
- Sozialwissenschaften Soziologie | Soziale Arbeit Spezielle Soziologie Gesundheitssoziologie, Medizinsoziologie
- Wirtschaftswissenschaften Volkswirtschaftslehre Gesundheitsökonomie
- Wirtschaftswissenschaften Wirtschaftssektoren & Branchen Fertigungsindustrie Pharmaindustrie
- Sozialwissenschaften Politikwissenschaft Regierungspolitik Umwelt- und Gesundheitspolitik
Weitere Infos & Material
PART I: THE GLOBAL HEALTH CARE CRISIS
1. The World's Health Care Crisis: The United States' Leadership
2. The Health Care Crisis in Other Parts of the World
PART II: UNDERSTANDING THE BIOPHARMACEUTICAL BUSINESS
3. Brief Commercial History of the Biopharmaceutical Industry up to the Year 2000
4. The Biopharmaceutical Industry in the Twenty-first Century: Titanic Challenges Ahead
5. Understanding Research and Development and Marketing in a Biopharmaceutical Company
6. The Pharmaceutical Regulators
PART III: THE COMPLEXITY OF INNOVATION
7. The Academia-Industry Relationship
8. Translating Academic Innovation into Health Care Products
9. The Biotechnology World and Its Challenges
10. Causes of the Pharmaceutical Crisis
PART IV: MORALITY AND DUTY ON A LONELY PLANET
11. Wealth versus Poverty
12. Social Responsibility, Governmental Role, and Nongovernmental Organizations
PART V: REINVENTING RESEARCH AND DEVELOPMENT
13. Time for Reorganization